Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion type Assertion NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_head.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion description "[The observed association between MET Y1253D-activating point mutation and decreased distant metastasis-free survival in advanced HNSCC suggests that MET may be a potential target for specific treatment interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_provenance.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion evidence source_evidence_literature NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_provenance.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion SIO_000772 19639388 NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_provenance.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion wasDerivedFrom befree-20150227 NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_provenance.
- NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_assertion wasGeneratedBy ECO_0000203 NP803158.RAcuIBCbL2dLbGABK5M55i_ouC9MZlaftKznzrLYlkbaQ130_provenance.